Skip to content
WeighLab
Menu
Ranked #447 · Grade C

Kin Meds review

Kin Meds is a GLP-1 telehealth provider whose own website could not be accessed for live verification due to active bot-protection/CAPTCHA (confirmed via direct fetch, a text-rendering proxy, and live browser automation).

Visit Kin Meds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Yes

Pricing verified August 2026

The Index scorecard

Kin Meds scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month45/100
Price Transparency54/100
Nationwide Access24/100
Formulation Options53/100
Clinical Oversight62/100
Contract Flexibility55/100

Where the value is

  • Appears to have an established web/social presence per search results

The tradeoffs

  • Site is unreachable for independent verification behind active bot/CAPTCHA protection
  • No pricing, medical director, or pharmacy partner could be confirmed directly from the company
  • Opaque to exactly the kind of scrutiny a shopper comparing options would want to apply
  • FDA issued Kin Meds a warning letter in February 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: Shoppers modeling the real monthly cost before they commit. Kin Meds is a GLP-1 telehealth provider whose own website could not be accessed for live verification due to active bot-protection/CAPTCHA (confirmed via direct fetch, a text-rendering proxy, and live browser automation).

Ranked #447 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Kin Meds.

The 18 programs nearest this one

Pricing, states and verification reflect Kin Meds's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Kin Meds's site. Not medical advice; see our disclosure.

← Back to the value leaderboard